Novo Nordisk has updated its Wegovy savings program, allowing eligible cash-paying patients to access the drug at retail pharmacies for a reduced cost of $499 per month.
Previously this option was available only through the recently launched NovoCare Pharmacy, according to a March 24 news release from the company.
The savings offer applies to all Wegovy dose strengths and replaces the previous $650 per month price for cash-paying patients. Those with commercial insurance that covers Wegovy may pay as little as $0 per month with a maximum savings of $225 per 28-day supply.
Patients enrolled in government-funded healthcare programs are not eligible, the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
